127 related articles for article (PubMed ID: 7656749)
1. B72.3 immunoreactivity in benign abdominal lymph nodes associated with gastrointestinal disease.
Loy TS; Haege DD
Dis Colon Rectum; 1995 Sep; 38(9):983-7. PubMed ID: 7656749
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
4. TAG-72 expression in lymph nodes and RIGS.
Hitchcock CL; Arnold MW; Young DC; Schneebaum S; Martin EW
Dis Colon Rectum; 1996 Apr; 39(4):473-5. PubMed ID: 8878513
[No Abstract] [Full Text] [Related]
5. Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases.
Loy TS; Nashelsky MB
Cancer; 1993 Oct; 72(8):2495-8. PubMed ID: 8402466
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic heterogeneity of a tumor-associated antigen in adenocarcinomas of the colon and their metastases as demonstrated by monoclonal antibody B72.3.
Lottich SC; Szpak CA; Johnston WW; Thor A; Schlom J
Cancer Invest; 1986; 4(5):387-95. PubMed ID: 2433005
[TBL] [Abstract][Full Text] [Related]
7. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of canine carcinomas with monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Delaney LJ
Vet Pathol; 1993 Mar; 30(2):140-5. PubMed ID: 8470336
[TBL] [Abstract][Full Text] [Related]
9. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
[TBL] [Abstract][Full Text] [Related]
10. Role of radioimmunoguided surgery using iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery.
Lucisano E; Bertoglio S
Semin Surg Oncol; 1998 Dec; 15(4):212-4. PubMed ID: 9829373
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patients.
Mariani-Costantini R; Muraro R; Ficari F; Valli C; Bei R; Tonelli F; Caramia F; Frati L
Cancer; 1991 Jun; 67(11):2880-6. PubMed ID: 1709062
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
14. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of canine epithelial and nonepithelial neoplasms with monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Morrison WB; Carlton WW
Vet Pathol; 1995 Mar; 32(2):147-54. PubMed ID: 7771055
[TBL] [Abstract][Full Text] [Related]
16. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
Shah SA; Gallagher BM; Sands H
J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases.
Takiyama Y; Tempero MA; Takasaki H; Onda M; Tsuchiya R; Büchler M; Ness M; Colcher D; Schlom J; Pour PM
Hum Pathol; 1989 Sep; 20(9):832-8. PubMed ID: 2673979
[TBL] [Abstract][Full Text] [Related]
19. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoguided surgery.
Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
Hepatogastroenterology; 1999; 46(30):3099-108. PubMed ID: 10626169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
